Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation (Q30805913)

26 June 2017

Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation (English)

1 reference

26 June 2017

Alexander L Schwarzman

1

1 reference

26 June 2017

Maria Tsiper

2

1 reference

26 June 2017

Luisa Gregori

3

1 reference

26 June 2017

Dmitry Goldgaber

4

1 reference

26 June 2017

Janusz Frakowiak

5

1 reference

26 June 2017

Bozena Mazur-Kolecka

6

1 reference

26 June 2017

Anastasia Taraskina

7

1 reference

26 June 2017

Sofia Pchelina

8

1 reference

26 June 2017

Michael P Vitek

9

1 reference

26 June 2017

1 December 2005

1 reference

26 June 2017

1 reference

26 June 2017

12

1 reference

26 June 2017

4

1 reference

26 June 2017

199-209

1 reference

Normal and abnormal biology of the beta-amyloid precursor protein

26 June 2017

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

The presenilins in Alzheimer's disease--proteolysis holds the key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Sequestration of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Screening for pharmacologic inhibitors of amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

A beta deposition inhibitor screen using synthetic amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Modified-peptide inhibitors of amyloid beta-peptide polymerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Bioavailability and transport of peptides and peptide drugs into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Libraries of peptides and proteins displayed on filamentous phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

Amyloid beta protein and transthyretin, sequestrating protein colocalize in normal human kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13506120500350762

10.1080/13506120500350762

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference